Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in Type 2 diabetic patients

被引：19
|
作者：
Negishi, Mayumi [1 ,2 ]
Shimomura, Kenju
Proks, Peter [3 ]
Shimomura, Yohnosuke [4 ]
Mori, Masatomo [2 ]
机构：
[1] Gunma Univ, Grad Sch Med, Heisei Hidaka Clin, Med Dept Diabet, Gunma 3700001, Japan
[2] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma 3700001, Japan
[3] Univ Oxford, HenryWellcome Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford, England
[4] Gunma Prefectural Coll Hlth Sci, Gunma, Japan
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 66卷 / 02期
关键词：
D O I：
10.1111/j.1365-2125.2008.03216.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [31] Factors associated with weight gain in type 2 diabetic patients starting on insulin: the CREDIT study
    Balkau, B.
    Home, P. D.
    Wang, E.
    Marre, M.
    DIABETOLOGIA, 2011, 54 : S53 - S53
  • [32] The Mechanisms by Which Pioglitazone Improves Insulin Sensitivity and Increases Body Weight in Patients with Type 2 Diabetes Mellitus
    Hirai, Hiroyuki
    Satoh, Hiroaki
    Kudoh, Akihiro
    Hasegawa, Koji
    Yamazaki, Satoru
    Sugaya, Yoshiyuki
    Fujiwara, Makoto
    Honma, Miyuki
    Nakajima, Shinichi
    Midorikawa, Sanae
    Watanabe, Tsuyoshi
    DIABETES, 2009, 58 : A360 - A360
  • [33] Relationship between changes in body weight and glycohemoglobin levels in patients with type 2 diabetes treated with diet or pioglitazone
    Ohmura, Eiji
    Ishida, Hidenori
    Tokunaga, Mitsugi
    Tsuchida, Atsuko
    Yazawa, Masako
    Matsuda, Akira
    Imai, Yasuo
    Kawazu, Shoji
    DIABETES, 2008, 57 : A734 - A734
  • [34] ACE inhibitor-induced cough in hypertensive type 2 diabetic patients
    Malini, PL
    Strocchi, E
    Fiumi, N
    Ambrosioni, E
    Ciavarella, A
    DIABETES CARE, 1999, 22 (09) : 1586 - 1587
  • [35] Clinical features of pneumatosis intestinalis induced by alpha- glucosidase inhibitor in patients with type 2 diabetes mellitus: a single center retrospective study
    Wu, Guanlin
    He, Weiheng
    Rao, Huimin
    Lu, Lin
    He, Xinran
    Hou, Xuewen
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [36] Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
    Kusaka, I.
    Nagasaka, S.
    Horie, H.
    Ishibashi, S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (11): : 1039 - 1046
  • [37] Effects of pretreatment with low-dose metformin on metabolic parameters and weight gain by pioglitazone in Japanese patients with type 2 diabetes
    Kawai, Toshihide
    Funae, Osamu
    Shimada, Akira
    Tabata, Mitsuhisa
    Hirata, Takumi
    Atsumi, Yoshihito
    Itoh, Hiroshi
    INTERNAL MEDICINE, 2008, 47 (13) : 1181 - 1188
  • [38] Effects of pioglitazone and insulin versus insulin therapy alone on weight gain and fat distribution in obese patients with type 2 diabetes
    Shah, Priya
    Mudaliar, Sunder
    Aroda, Vanita
    Wilson, Janet
    Andre, Michael
    Chao, Edward
    Kouse, Jennifer
    Burke, Paivi
    Henry, Robert
    DIABETES, 2008, 57 : A142 - A142
  • [39] Alogliptin added to pioglitazone therapy improves glycaemic control in patients with type 2 diabetes without increasing weight gain or hypoglycaemia
    Pratley, R.
    Reusch, J.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2008, 51 : S343 - S343
  • [40] Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models
    Suzuki, M.
    Takeda, M.
    Kito, A.
    Fukazawa, M.
    Yata, T.
    Yamamoto, M.
    Nagata, T.
    Fukuzawa, T.
    Yamane, M.
    Honda, K.
    Suzuki, Y.
    Kawabe, Y.
    NUTRITION & DIABETES, 2014, 4 : e125 - e125
12345